e-learning
resources
Stockholm 2007
Monday 17.09.2007
Diagnostic markers and therapy in hospital-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nosocomial pneumonia: most frequent infecting agents and patients‘ smoking status
K. Gashynova, K. Bogats‘ka (Dnipropetrovs‘k, Ukraine)
Source:
Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Session:
Diagnostic markers and therapy in hospital-acquired pneumonia
Session type:
Thematic Poster Session
Number:
2420
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Gashynova, K. Bogats‘ka (Dnipropetrovs‘k, Ukraine). Nosocomial pneumonia: most frequent infecting agents and patients‘ smoking status. Eur Respir J 2007; 30: Suppl. 51, 2420
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The prevalence of smoking in HIV-infected patients with community-acquired pneumonia
Source: International Congress 2015 – Epidemiology, public health and economics of tobacco
Year: 2015
Nosocomial pneumonia: influence of smoking on the course of disease
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
The impact of smoking on respiratory infections in HIV-infected patients
Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products
Year: 2015
Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
The influence of smoking habit in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Nosocomial pneumonia: treatment and prevention
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
The influence of anxiety on the behavior of smoking in patients with community-acquired pneumonia
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Nosocomial superinfection is one of the principal cause of mortality in severe community-acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens
Source: Eur Respir J 2006; 28: Suppl. 50, 785s
Year: 2006
The prevalence of cardiac diseases in patients with community-acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia
Source: Eur Respir J 2009; 33: 394-400
Year: 2009
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Source: Eur Respir J 2008; 32: 139-146
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept